Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Clinical trial NCT00531284 · COMPLETED

Trial details

NCT number: NCT00531284
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Renal Cancer Non-small Cell Lung Cancer Small Cell Lung Cancer Solid Tumors Multiple Myeloma Lymphoma

Start date: 2007-09-01
Primary completion: 2014-10-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.